20.02.11 Protein based techniques Flashcards

1
Q

Name 4 protein-based techniques

A
  1. Western blotting
  2. Immunoprecipitation
  3. Immunohistochemistry
  4. Mass spectrometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does western blotting do

A

-Separates proteins by electrophoresis, which is then transferred to an adsorbent membrane where antibodies detect protein of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Uses of western blotting

A
  • Proves the absence/ presence of protein
  • Compares protein levels across different tissues/ physiological conditions/ development.
  • To assess purity
  • Estimate relative molecular mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

WB step 1- Sample preparation steps.

A
  • Lyse cells/ tissue to release proteins. Often buffers have protease inhibitors to prevent degradation of proteins.
  • If blot is being used for quantitative purposes then protein conc should be determined (BCA assay)
  • Loading dyes used to track migration of sample through gel.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

WB step 2- Protein separation by SDS-PAGE

A
  • PAGE= polyacrylamide gel electrophoresis
  • Proteins separated by molecular weight. Done under denaturing conditions (using SDS, a detergent).
  • SDS also gives proteins a negative charge (proportional to length). Therefore proteins separated by MW not charge.
  • Non-denaturing conditions needed for antibody recognition. Here samples are not heated or exposed to SDS. Proteins usually have a negative charge in alkaline buffers so migration still occurs.
  • 2D PAGE. When a gradient pH is present. pH changes the charge on the protein. Proteins run to their isoelectric point (pH where net charge is zero). The next separation is then based on MW. Used to separate complex samples.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WB step 3- Blotting

A
  • Proteins transferred from gel to membrane by diffusion, an electric field or a vacuum
  • Gel and paper is sandwiched between absorbent material and submerged in transfer buffer and an electrical field applied. Proteins travel towards positive charged electrode and bind to membrane.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

WB step 4- antigen detection

A
  • Membrane is washed with non-fat milk to prevent non-specific binding of antibody.
  • Direct detection- primary antibody detects antigen on blot and is labelled
  • Indirect detection. Primary antibody binds to antigen and a secondary labelled antibody binds to the primary.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

WB step 5- visualisation

A
  • chomogenic= enzyme coupled antibodies, e.g. HRP (horseradish peroxidase). Substrates added which yield visible coloured products
  • Chemiluminescent detection. Substrates produce a chemiluminescent product (CPD), which is detectable on X-ray film
  • Fluorescent detection- secondary antibodies are coupled to fluorochromes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is immunoprecipitation

A
  • Antibody immobilized support that enriches/ purifies a protein from a sample.
  • Purified proteins can then be quantified/ analysed by other techniques e.g. Western blotting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Two methods for immunoprecipitation

A
  1. Pre-immobilised approach. Antibody is pre-immobilised onto an insoluble support and incubated with lysate containing the target protein. Protein binds to antibody, remaining material washed away. The protein of interest is then eluted.
  2. Free-antibody approach. Free unbound antibody forms immune complexes in lysate. Complexes are then isolated using beads. Beneficial if antibody has weak affinity for antigen or binding kinetics are slow.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is co-immunoprecipitation

A
  • Co-IP can identify physiologically relevant protein-protein interactions.
  • Protein specific antibodies indirectly capture proteins that bind to the target protein.
  • Uses= identify new binding partners, binding affinities, biding kinetics, functions of target proteins.
  • Pull down assays= not using antibodies, i.e. covalent attachment or affinity tags
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Chromatin IP

A
  • Selective enrichment of a chromatin fraction containing a specific protein.
  • Antibodies used to immunoprecipitated proteins of interest along with associated DNA.
  • Uses= gives insight into gene regulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Application of IP in routine testing

A
  • Useful to determine effect of missense mutations on protein-protein interactions, half-life, subcellular location.
  • Not really amenable to routine testing.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is immunohistochemistry (IHC)

A
  • Localises specific antigens in tissues using antibodies. Typically visualised using an antibody conjugated with an enzyme (peroxidase) which catalyses a colour-producing reaction.
  • Gives evidence on presence/ absence/ localisation of a protein. Also tissue structure and cellularity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Difference between immunohistochemistry (IHC) and immunocytochemistry (ICC)

A
  • IHC= uses sections of tissue (cells surrounded by matrix)

- ICC= uses cells with matrix removed, eg. cultured cells/ suspension/ smear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Difference between monoclonal and polyclonal antibodies

A
  • Monoclonal= recognise a single epitope on an antigen. Less likely to cross react
  • Polyclonal= recognises multiple epitopes on any one antigen. Cheaper and easier to produce.
17
Q

Advantages of IHC

A
  • Fast TAT, cost effective

- Provides positional information

18
Q

Disadvantages of IHC

A
  • Antibody cross-reactivity (can lead to false positives)
  • Variability in fixation and processing (need to use controls)
  • Not quantitative
  • Not high-throughput
  • Need pathologist expertise to analyse and interpret.
  • Does not detect truncated or abnormal proteins with intact epitopes.
19
Q

Give examples of IHC in diagnosing genetic conditions

A
  • IHC for MMR proteins in tumour tissues for Lynch syndrome.
  • IHC with EGFR mutation-specific antibodies to detect responders to gefitinib in lung adenocarcinoma. Good for samples with low tumour cell content but has false positives and false negatives.
20
Q

What is mass spectrometry

A
  • Measures mass-to-charge ratio (m/z) of one or more molecules. Calculates exact molecular weight of sample components.
  • Can be used to identify unknown compounds, quantify known compounds, and to determine the structure and chemical properties of molecules.
21
Q

`What is a mass spectrometer comprised of

A
  1. Ionisation source: Molecules converted to gas-phase ions so they can be moved by electric/magnetic fields
  2. Mass analyser: ions sorted and separated according to m/z ratios
  3. Ion detection system: separated ions measured and sent to data system for storage (along with their relative abundance).
22
Q

How are results of MS plotted

A
  • m/z ratios of ions are plotted against their intensities.

- Each peak shows a component of unique m/z. Height shows relative abundance.

23
Q

How can MS be used for peptide/ protein analysis

A
  • determine amino acid sequence
  • Characterise post-translational modifications (phosphorylation/ glycosylation)
  • determine absolute and relative protein quantities
  • Identify proteins from complex samples
  • Examine isoform expression
24
Q

What is SELDI-TOF MS

A
  • Surface enhanced laser desorption/ ionisation time of flight mass spectrometry
  • Biochemical characteristics of surfaces are used to bind specific protein/peptides (PPs) - i.e. hydrophobicity, electrostatic interaction, affinity chromatography
25
Q

How does SELDI-TOF work

A
  1. The sample is applied to a modified chip surface, which binds specific proteins to the surface.
  2. Contaminants and unbound proteins are then washed away.
  3. an energy absorbing matrix is applied to the surface and allowed to crystallize with the sample
  4. An irradiating laser ionizes peptides from crystals of the sample/matrix mixture to form ions.
  5. The ions are then briefly accelerated through an electric potential and separated by their velocity differences.
  6. mass-to-charge ratio of each ion determined (velocity of the ions is inversely proportional to the square root of the mass-to-charge ratio of the ion; ions with low mass-to-charge ratios are detected earlier than ions with high mass-to-charge ratios)
  7. Combined protein spectra for each sample are compared to known controls.
26
Q

What is MALDI-TOF MS

A
  • Matrix assisted laser desorption/ionisation time of flight mass spectrometry
  • Can be used for mutation detection
27
Q

Give two examples of protein microarrays

A
  • Protein capture agents. E.g. antibodies. Used to assay abundance of proteins
  • Arrays containing proteins/peptides. Used to study protein interactions.
  • Can be used to detect disease, response to therapy (protein profiling of biological fluids), detect post-translational protein modifications.
28
Q

What is proteomics

A

Comprehensive, integrative study of proteins and their biological functions. Map of the proteome.

29
Q

WHat are some major research areas of proteomics

A
  • Biomarkers (protein markers of disease)
  • Interactions (protein- protein, protein-drug)
  • Signalling pathways
  • Epigenetics (histone modification in development and disease)
  • Proteogenomics= discovery of novel protein-coding regions, new translation initiation sites etc.
  • issue with proteomics is that it relies on the assumption that current gene models are correct and that the correct protein sequences can be found using a reference protein sequence database
30
Q

Advantages of MS

A
  • Comprehensive profiles of proteins without the need of protein separation
  • requires small amount of sample
  • High specificity and sensitivity
  • High throughput, cost effective (suitable for screening)
31
Q

Limitations of MS

A
  • MS results could be affected by conditions of sample/ patient (e.g. freeze thaws, sample processing and storage, populations, nutrition, drugs)
  • Low level proteins may be masked by high level proteins
  • Preferential detection of proteins with a lower MW
  • Cost of commercial microarrays
32
Q

Use of MS in diagnosis of genetic conditions

A
  • Protein chips used to classify cancers (benign hyperplasia vs cancer), early detection
  • Tandem MS for Newborn screening of metabolic disorders (PKU, MCADD)
33
Q

What is Tandem MS (or MS/MS)

A
  • where two or more mass analyzers are coupled together using an additional reaction step
  • The molecules of a given sample are ionized and the first spectrometer (MS1) separates these ions by their mass-to-charge ratio.
  • Ions of a particular m/z-ratio coming from MS1 are selected and then made to split into smaller fragment ions
  • These fragments are then introduced into the second mass spectrometer (MS2), which in turn separates the fragments by their m/z-ratio and detects them.
  • The fragmentation step makes it possible to identify and separate ions that have very similar m/z-ratios in regular mass spectrometers.